Package 68788-4067-9

{"route": ["ORAL"], "spl_id": "68b22d22-c2d3-4e90-b302-56f7cb731427", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199890"], "spl_set_id": ["68b22d22-c2d3-4e90-b302-56f7cb731427"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-4067-3)", "package_ndc": "68788-4067-3", "marketing_start_date": "20260128"}, {"sample": false, "description": "15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-4067-5)", "package_ndc": "68788-4067-5", "marketing_start_date": "20260128"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-4067-6)", "package_ndc": "68788-4067-6", "marketing_start_date": "20260128"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-4067-9)", "package_ndc": "68788-4067-9", "marketing_start_date": "20260128"}], "brand_name": "topiramate", "product_id": "68788-4067_68b22d22-c2d3-4e90-b302-56f7cb731427", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-4067", "generic_name": "topiramate", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA090162", "marketing_category": "ANDA", "marketing_start_date": "20260128", "listing_expiration_date": "20271231"}